Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
In Brief

Fred Hutch announces eight recipients of 2024 Eddie Méndez Scholar Award

June 21, 2024
Vol.50 No.25
Most cancer centers provide paltry resources for meeting NCI’s CCSG mandate to enhance diversity, study shows

Most cancer centers provide paltry resources for meeting NCI’s CCSG mandate to enhance diversity, study shows

June 07, 2024
Vol.50 No.23
By Matthew Bin Han Ong
Fred Hutch’s Christopher Li: Cancer centers should commit more resources to meet NCI’s Plan to Enhance Diversity requirements
Conversation with The Cancer Letter

Fred Hutch’s Christopher Li: Cancer centers should commit more resources to meet NCI’s Plan to Enhance Diversity requirements

June 07, 2024
Vol.50 No.23
By Matthew Bin Han Ong
Clinical Roundup

One in five people with cancer participate in medical research studies, Fred Hutchinson study shows

April 05, 2024
Vol.50 No.14
In Brief

Denene Prophet-Williams named vice president and chief nursing officer at Fred Hutchinson

March 08, 2024
Vol.50 No.10
In Brief

Twelve graduate students receive Fred Hutchinson 2024 Harold M. Weintraub Graduate Student Award

March 08, 2024
Vol.50 No.10
Clinical Roundup

Fred Hutch establishes free AI-powered chatbot app to help people quit smoking

January 26, 2024
Vol.50 No.04
In Brief

Fred Hutch names eight recipients of 2023 Dr. Eddie Méndez Scholar Award

October 20, 2023
Vol.49 No.39
In Brief

Lawrence Fong named scientific director of Immunotherapy Integrated Research Center at Fred Hutch

October 13, 2023
Vol.49 No.38
In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
FreeIn the Archives

In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch

September 15, 2023
Vol.49 No.34
By Deborah Doroshow and Alexandria Carolan

Posts navigation

Previous1…3456Next

Trending Stories

  • As daraxonrasib hits the clinic, Frank McCormick says RAS is bigger than pancreatic cancer
  • Is it time to re-assess the practice and practicality of screening colonoscopy?
    Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives
  • Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
  • Cancer leaders play “musical chairs” as executive jobs fill at top cancer centers
    Lee replaces Pisters at MD Anderson, Tuveson moves to Duke, and Mitchell is named director at University of Florida
  • From “default dead” to living the future of cancer care
    As founding CEO of GitLab, I went “founder mode” on my osteosarcoma
  • mRNA vaccine for melanoma is hailed as a turning point in medicine
    The data from Moderna and Merck’s trial have yet to be presented

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account